ATLANTA, Feb. 8, 2011 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq:ALIM) (“Alimera”), a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that Dan Myers, president and chief executive officer, will present at the 13th Annual BIO CEO & Investor Conference at 9:30 A.M. ET on February 15, 2011 at The Waldorf=Astoria in New York City.
